The Intellectual Property portfolio of TIGR® Matrix Surgical Mesh has been further complimented with the granting of a second U.S. patent related to material degradation and mechanical behaviour. TIGR® Matrix was developed based on the hypothesis that soft tissue positively remodels in response to the stimulus of increased mechanical load – a process known as ’mechanotransduction’, which is the physiological process by which cells sense and respond to mechanical loads. This key feature contributes to the functional regenerated tissue that ultimately replaces the degraded mesh, as shown in preclinical trials. (ref: http://www.springerlink.com/content/c033k26015677312/)
Subscribe to the RSS feed or if you want to get our press releases emailed to you, enter your email in the box to the right.
-
27 December, 2011
Novus Scientific Announces a New U.S. Patent for a Mesh Implant Comprising Two Different Resorbable Materials with Different Degradation Times and Specific Mechanical Behaviours; U.S. Patent No. – 8,083,755
-
21 December, 2011
Novus Scientific Leads Evolution of Long-Term Absorbable Meshes on the Soft Tissue Repair Market with TIGR® Matrix Surgical Mesh
Singapore /mynewsdesk/ — Novus Scientific today announced that the successful adoption of long-term absorbable surgical meshes in the market for soft tissue repair devices has been acknowledged in a new report issued by Millennium Research Group, Inc. The report, “U.S. Markets for Soft Tissue Repair 2012” highlights that synthetic absorbable meshes are beginning to compete for sales within the market by offering the benefits of both biologic products and non-absorbable synthetic meshes.
-
8 November, 2011
TIGR® Matrix Surgical Mesh and hernia study results presented at the 7th International Congress of the Asia Pacific Hernia Society 2011.
Singapore / MyNewsDesk / Novus Scientific Pte. Ltd today announced that TIGR® Matrix Surgical Mesh, the World’s 1st Long-Term Resorbable Synthetic Mesh will be launched at APHS 2011 (www.aphs2011.org/) in Hua Hin, Thailand, from November 9th – 11th, 2011.
This event has been postponed to Jan 11-13, 2012, due to the floods in Thailand.
-
13 October, 2011
Novus Scientific Announces New U.S. Patent for Mesh Implant with an Interlocking Knitted Structure; TIGR® Matrix Surgical Mesh – US 8,016,841
The unique features of TIGR® Matrix Surgical Mesh have been recognized with the first U.S. patent now granted.
-
6 October, 2011
Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh
Singapore / Novus Scientific today announced the peer-reviewed publication of unique pre-clinical data on TIGR® Matrix Surgical Mesh – the world’s first long-term absorbable surgical mesh.
-
20 September, 2011
Novus Scientific Announces the Worlds 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh.
Singapore /MyNewsDesk/ — Novus Scientific today announced TIGR® Matrix Surgical Mesh, the world’s first and only long-term resorbable (100% absorbable) mesh, as an alternative to permanent synthetic mesh. First introduced in the US in 2010, TIGR® Matrix Surgical Mesh is currently being used in many surgical applications as an alternative to permanent synthetic mesh and expensive biologic devices.
-
Novus Scientific Announces TIGR® Matrix Surgical Mesh Distribution Agreements in Major European Markets.
Singapore /MyNewsDesk/ —Novus Scientific today announces that TIGR® Matrix distribution agreements have been signed with partners in France, Italy (including the Vatican and San Marino), Spain, the United Kingdom (including Northern Ireland) and Switzerland. Direct sales have begun in Sweden, while suitable partners are being sought in other European countries.
-
16 August, 2011
Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh – the World’s First Long-Term Resorbable Synthetic Mesh.
Singapore /PRNewswire/ — Novus Scientific Pte. Ltd announced today that it has received CE Mark approval for TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic mesh. TIGR® Matrix is indicated for reinforcement of soft tissue where weakness exists.
-
15 June, 2011
Novus Scientific Announces Approval of New Clinical Trial in Hernia Repair with Tulane University and VA Medical Center, New Orleans at “Abdominal Wall Reconstruction 2011” Congress
Novus Scientific today announced that Tulane University School of Medicine and Department of Veterans Affairs have granted IRB approval to a new trial: A Study Evaluating Efficacy of TIGR® Matrix Surgical Mesh used in Elective Open Inguinal Hernia Repair.
-
1 June, 2011
Novus Scientific and Florida Hospital announce “ADVANCES in ABDOMINAL SURGERY: A symposium for General Surgeons & Plastic Surgeons in Florida”
Novus Scientific today announced the joint sponsorship with Florida Hospital of; ‘ADVANCES in ABDOMINAL SURGERY: a symposium for General Surgeons & Plastic Surgeons in Florida’ to be held June 2nd, 2011. This is the first “SOFTissue – The Issue of Soft Tissue” educational series to be conducted in the U.S. and will be held at the Creation Conference Center at Florida Hospital, Orlando, FL. (program and registration available here).
-
23 May, 2011
Use of TIGR® Matrix Surgical Mesh in Multi-Center Randomized Controlled TRAM Flap Study passes 20 patient mark and wins praise from participating surgeons.
Singapore, /PRNewswire/ — Singapore company Novus Scientific Pte. Ltd announced that the TRAM Flap study (Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh) has passed the 20 patient mark, representing approximately one quarter of the 86 patient study compliment.
-
10 May, 2011
TIGR® Matrix Surgical Mesh – Exhibited ahead of anticipated CE Mark Approval at European Hernia Society 2011, Ghent, Belgium
Singapore /PRNewswire/ — Novus Scientific Pte. Ltd today announced that it will be exhibiting at EHS 2011 in Ghent, Belgium ahead of receiving its anticipated CE Mark approval this year for TIGR® Matrix Surgical Mesh, the World’s 1st Long-Term Resorbable Synthetic Mesh.
-
25 January, 2011
Surgeons at University of California San Diego perform 1st TRAM Flap procedure in an international Multi-Center Study using TIGR® Matrix Surgical Mesh, the World’s 1st long-term resorbable mesh.
Novus Scientific Pte. Ltd, a Singapore company, announced today that Dr. James Chao of the University of California San Diego (UCSD) has operated on his first TRAM Flap patient using TIGR® Matrix Surgical Mesh.
-
3 November, 2010
Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) host the inaugural event of “SOFTISSUE – The Issue of Soft Tissue”, Featuring James J Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of California, San Diego
Singapore company Novus Scientific Pte. Ltd today announced the successful hosting of Asia’s 1st “SOFTISSUE – The Issue of Soft Tissue” educational series, together with the Singapore Association of Plastic Surgeons (SAPS) on 1st November 2010.
-
25 October, 2010
National University Hospital Singapore operates on Asia’s 1st TRAM Flap patient using TIGR® Matrix Surgical Mesh, the World's 1st long-term resorbable mesh
Singapore company Novus Scientific Pte. Ltd today announced that the National University Hospital (NUH), Singapore has operated on the first patient in it’s groundbreaking study: Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® Matrix (100% Resorbable) vs Polypropylene (Permanent) Mesh
-
13 September, 2010
National University Hospital Singapore receives DSRB approval to use TIGR® Matrix Surgical Mesh in a new randomized controlled TRAM Flap study
Novus Scientific Pte. Ltd today announced that the National University Hospital (NUH), Singapore has received Domain Specific Review Board (DSRB i.e. IRB equivalent) provisional approval for a new study: Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh
-
21 June, 2010
Novus Scientific Announces the Sales Launch for TIGR® Matrix Surgical Mesh – World's 1st Long-Term Resorbable Synthetic Mesh
CANTON, Mass., June 17 /PRNewswire/ — Novus Scientific, Inc. today announced the US sales launch of TIGR® Matrix Surgical Mesh at the Abdominal Wall Reconstruction meeting, Washington DC. In February 2010, the US Food and Drug Administration (FDA) cleared, TIGR® Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists.
-
19 March, 2010
Novus Scientific presents initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh – The world’s 1st long-term resorbable synthetic mesh
Novus Scientific Pte. Ltd today announced the presentation of initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh. The study results were presented today at the American Hernia Society Meeting in Orlando, Florida by Dr. Fernando Ruiz-Jasbon, Consultant Surgeon at Kungsbacka Hospital / Gothenburg University, Sweden.
In the study, 40 patients with primary inguinal hernias were enrolled and TIGR® Matrix was implanted for hernia repair. Clinical outcome is being assessed at 0.5, 1, 3, 6 and 12 months. In preliminary follow-up, there have been no serious adverse events and the mean pain score assessed when coughing fell from 17.4 prior to surgery to 0.3 at 6 months (on a scale of 0-100).
-
7 March, 2010
CK Team Novus Scientific stand on the Podium in Singapore’s OCBC 50km Super Challenge
Uppsala company Novus Scientific AB (Headquartered in Singapore) led by CEO Thomas Engström, has been making headlines overseas again. This time, not by gaining regulatory approval for it’s ’World’s 1st’ TIGR® Matrix Surgical Mesh (a long-term resorbable, 100% synthetic mesh for hernia repair), but for 3rd place in the prestigious OCBC Cycle Singapore competition, 50km Super Challenge course.
-
5 February, 2010
Novus Scientific Receives FDA Clearance for TIGR® Matrix Surgical Mesh – World’s 1st long-term resorbable synthetic mesh
CANTON, MA Novus Scientific Pte. Ltd today announced that the US Food and Drug Administration (FDA) has given the company 510(k) clearance to market the TIGR® Matrix Surgical Mesh, for use in reinforcement of soft tissues where weakness exists. TIGR® Matrix Surgical Mesh is a 100 percent resorbable, synthetic matrix, knitted from two different resorbable fibers that degrade at different rates following implantation. This unique patented dual-fibre design provides an initial high strength / high stability configuration, with gradually increasing mechanical compliance over time as the product is resorbed. The macroporous structure is designed to allow tissue integration for reliable tissue repair.
